| 000 | 01002 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250518011317.0 | ||
| 264 | 0 | _c20191025 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.18.00364 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Ziyu | |
| 245 | 0 | 0 |
_aPHOENIX-GC Trial: Underpowered for Significant Results? _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c01 2019 |
||
| 300 |
_a167 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aCisplatin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPaclitaxel |
| 650 | 0 | 4 | _aPeritoneal Neoplasms |
| 700 | 1 | _aXue, Kan | |
| 700 | 1 | _aYing, Xiangji | |
| 700 | 1 | _aJi, Jiafu | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 37 _gno. 2 _gp. 167 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.18.00364 _zAvailable from publisher's website |
| 999 |
_c29090044 _d29090044 |
||